 | FRI, OCT 16, 2020 | | | | Think a friend or colleague should be getting this newsletter? Share this link with them to sign up.
Friday marks the deadline for state health officials across the United States to submit draft plans to the federal government on how they will distribute Covid-19 vaccines if and when they are approved for public use. The CNBC health team has an analysis. We also have a packed newsletter this week with updates on U.S. health-care workers, Covid-19 clinical trials, herd immunity and more.
| | American health workers are looking abroad for opportunities | Over the past few months, we've been having conversations with U.S. doctors looking to relocate during this pandemic – specifically, to New Zealand. A spokesperson for Global Medical Staffing, a recruitment group that helps doctors find short- and long-term positions around the world, noted that inquiries have increased about relocating to New Zealand from the U.S. as more physician jobs have been affected during the pandemic. So why are health workers making the move? It's a combination of factors from general burnout to the anti-science rhetoric. As one doctor told us: "America will suffer an exodus of professionals to other countries that have responded better, with economies that have recovered faster."
-Chrissy Farr | | | | Seven months into the pandemic, PPE is still a problem | Back in March, a group of doctors banded together to form Get Us PPE, a nonprofit that looked to fill gaps in the personal protective gear they needed to safely care for Covid-19 patients. The group expected to be around for a couple weeks, maybe a month. Seven months later, they're needed more than ever. While supply chains have improved since the spring, even big hospital systems tell us they're having to find workarounds – and everyone is worried about what that means for a potential surge of cases through the fall and winter.
-Meg Tirrell | | | | Covid-19 clinical trials are pausing over safety concerns – what that means | Coronavirus clinical trials from drug giants Johnson & Johnson and Eli Lilly hit a snag this week after safety monitors halted them over bad reactions from participants. But pauses to clinical trials are not uncommon, and the delays should reassure the public that the systems in place intended to protect volunteers are working, medical experts told me. The data and safety monitoring board, or DSMB, recommends a pause to a clinical trial any time there is an "adverse event." The pause will take as long as needed to gather all information and does not necessarily mean there is a problem with the vaccine or treatment, experts said.
-Berkeley Lovelace Jr. | | | | Trying to preempt the Twindemic | A highlight of Walgreens earnings this week was a beat on same-store sales, driven by strong demand for its customizable masks. In the current quarter, COO Alex Gourlay told me the pharmacy is seeing strong demand for flu shots, as consumers try to protect themselves from influenza amid a new wave of Covid-19 cases. UnitedHealth Group's profits declined year over year, in part because the company has been spending more to get patients to seek preventive care. This flu season, the insurer is sending flu-Covid kits to vulnerable Medicare members to get ahead of potential exposure to the viruses this winter.
-Bertha Coombs | | | | Airborne virus transmission makes air filters as popular as 'toilet paper in April' | Evidence has been mounting for months that the coronavirus can spread by air, driving demand for high-quality air filters and proper ventilation systems that can reduce the risk of spread. Investing in air quality is no silver bullet, but as the weather turns colder and people spend more time indoors, it's another layer of a multipronged defense against the virus. But like so many products suddenly in hot demand due to the pandemic, high-quality air filters and supplies for ventilation systems are flying off the shelves, causing a backlog of more than a month for some customers, Jim Rosenthal, CEO of Tex-Air Filters, told me. "It's like toilet paper in April times two," he said.
-Will Feuer | | | | Coronavirus survive for 28 days on common surfaces, research says | The coronavirus can survive for 28 days on surfaces such as glass, steel, vinyl, paper and polymer banknotes, Australian researchers said, reinforcing the importance of effective cleaning and handwashing to curb the spread of Covid-19. The study, which was peer reviewed, also found the virus was "extremely robust" at lower temperatures, remaining infectious for a longer period when compared with higher temperatures.
-Sam Meredith | | | | Dr. Fauci says letting the virus spread unchecked is 'nonsense' | White House coronavirus advisor Dr. Anthony Fauci said the idea of achieving so-called herd immunity against the coronavirus is "nonsense" and "dangerous," and allowing the virus to rip through the U.S. population unchecked would cause a lot of unnecessary deaths, he said. Fauci was asked about the "Great Barrington Declaration," an online movement that favors herd immunity and was mentioned by a senior White House official on a call with reporters on Monday. "Quite frankly that is nonsense, and anybody who knows anything about epidemiology will tell you that that is nonsense and very dangerous," Fauci told Yahoo! News. He said he has made his position on herd immunity known with the White House and added that Dr. Deborah Birx, the administration's coronavirus task force coordinator, and Dr. Robert Redfield, director of the U.S. Centers for Disease Control and Prevention, agree.
-Noah Higgins-Dunn | | | | A 25-year-old man becomes first in the U.S. to contract coronavirus twice | A 25-year-old man in Nevada has contracted the coronavirus on two separate occasions, a study in the Lancet Infectious Diseases journal showed, with the patient becoming seriously ill following the second infection. It is the first confirmed case of a U.S. patient becoming reinfected with Covid-19, and the fifth known case reported worldwide. He has now recovered, though the case raises further questions about the prospect of developing protective immunity against the coronavirus.
-Sam Meredith | | CNBC Evolve Summit | November 10, 2020
In an era of rapid technological advances and demographic change, how do legacy companies adapt, innovate and evolve?
CNBC Evolve features iconic global companies and executives who are embracing change and transforming for the future.
Featuring best-in class CEOs and innovators in conversation with CNBC anchors and reporters, this event provides a forum for companies to share strategies, tactics and lessons learned in a peer-to-peer environment.
Attendees will walk away with an understanding of how businesses and brands can evolve and win in an age of disruption.
Featured speakers include:
Al Kelly, Visa
Lisa Safarian, Bayer North America
Arvind Krishna, IBM
Tom Hayes, Ocean Spray
Kelly Caruso, Shipt
Stan Kasten, Los Angeles Dodgers
Lisa Deverell, Land O'Lakes
Darius Adamczyk, Honeywell
| |
★↠∺〖@NetFlix!〗 2020 Este cuerpo me sienta de muerte PelÃcula Completa En LÃnea released 2020. story: Tras intercambiar su cuerpo con un as...
Post a Comment